| 1 |
33450317 | Overcoming therapeutic efficiency limitations against TRAIL-resistant tumors using re-sensitizing agent-loaded trimeric TRAIL-presenting nanocages. | 2021 Mar 10 |
6 |
| 2 |
34360606 | Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells. | 2021 Jul 22 |
1 |
| 3 |
32365976 | Chemotherapeutic Agents Sensitize Resistant Cancer Cells to the DR5-Specific Variant DR5-B more Efficiently than to TRAIL by Modulating the Surface Expression of Death and Decoy Receptors. | 2020 Apr 30 |
1 |
| 4 |
33321722 | Transferrin-Bound Doxorubicin Enhances Apoptosis and DNA Damage through the Generation of Pro-Inflammatory Responses in Human Leukemia Cells. | 2020 Dec 10 |
1 |
| 5 |
31817469 | Double-Edged Lipid Nanoparticles Combining Liposome-Bound TRAIL and Encapsulated Doxorubicin Showing an Extraordinary Synergistic Pro-Apoptotic Potential. | 2019 Dec 5 |
7 |
| 6 |
29268009 | Reduction Responsive Nanovesicles Derived from Novel α-Tocopheryl-Lipoic Acid Conjugates for Efficacious Drug Delivery to Sensitive and Drug Resistant Cancer Cells. | 2018 Feb 21 |
6 |
| 7 |
29521001 | Manipulating multifaceted microbubble shell composition to target both TRAIL-sensitive and resistant cells. | 2018 Jul |
4 |
| 8 |
28300219 | Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes. | 2017 Mar 16 |
1 |
| 9 |
28702823 | Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis. | 2017 Oct |
4 |
| 10 |
28771937 | Shell effects on acoustic performance of a drug-delivery system activated by ultrasound. | 2017 Nov |
2 |
| 11 |
28814080 | Drug Delivery from a Multi-faceted Ultrasound Contrast Agent: Influence of Shell Composition. | 2017 Oct 2 |
1 |
| 12 |
29263663 | Multifunctionalized polyethyleneimine-based nanocarriers for gene and chemotherapeutic drug combination therapy through one-step assembly strategy. | 2017 |
1 |
| 13 |
26526555 | Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer. | 2016 Mar |
7 |
| 14 |
26641559 | Layer by layer assembly of albumin nanoparticles with selective recognition of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). | 2016 Mar 1 |
4 |
| 15 |
26794656 | Flavonol and imidazole derivatives block HPV16 E6 activities and reactivate apoptotic pathways in HPV⁺ cells. | 2016 Jan 21 |
1 |
| 16 |
27557520 | Synergistic effect of reduced polypeptide micelle for co-delivery of doxorubicin and TRAIL against drug-resistance in breast cancer. | 2016 Sep 20 |
6 |
| 17 |
25445703 | Inhalable self-assembled albumin nanoparticles for treating drug-resistant lung cancer. | 2015 Jan 10 |
1 |
| 18 |
26227206 | Pre-activated human mesenchymal stromal cells in combination with doxorubicin synergistically enhance tumor-suppressive activity in mice. | 2015 Oct |
3 |
| 19 |
26547077 | Mutations Enhancing Selectivity of Antitumor Cytokine TRAIL to DR5 Receptor Increase Its Cytotoxicity against Tumor Cells. | 2015 Aug |
1 |
| 20 |
24013224 | Inhibition of the mitochondrial pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase by doxorubicin and brequinar sensitizes cancer cells to TRAIL-induced apoptosis. | 2014 Jul 3 |
4 |
| 21 |
23504627 | Doxorubicin sensitizes human tumor cells to NK cell- and T-cell-mediated killing by augmented TRAIL receptor signaling. | 2013 Oct 1 |
2 |
| 22 |
23993342 | Choline transporter-targeting and co-delivery system for glioma therapy. | 2013 Dec |
2 |
| 23 |
24332050 | [Effect of doxorubicin on TRAIL resistance and TRAIL receptor expression in lymphoma cell line SNK-6 cells]. | 2013 Sep |
8 |
| 24 |
32260806 | Fabrication of tumor necrosis factor-related apoptosis inducing ligand (TRAIL)/ALG modified CaCO3 as drug carriers with the function of tumor selective recognition. | 2013 Mar 7 |
4 |
| 25 |
22077238 | Aclarubicin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis through death receptor 5 upregulation. | 2012 Feb |
2 |
| 26 |
22118776 | Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. | 2012 Feb |
1 |
| 27 |
22133146 | Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL. | 2012 Feb 3 |
1 |
| 28 |
22484049 | Gene and doxorubicin co-delivery system for targeting therapy of glioma. | 2012 Jun |
1 |
| 29 |
22753761 | TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells. | 2012 Jul |
2 |
| 30 |
23142520 | Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity. | 2012 Dec 7 |
1 |
| 31 |
20971503 | Plasmid pORF-hTRAIL and doxorubicin co-delivery targeting to tumor using peptide-conjugated polyamidoamine dendrimer. | 2011 Feb |
2 |
| 32 |
21514380 | Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc. | 2011 Jul |
2 |
| 33 |
21586819 | A novel combination of TRAIL and doxorubicin enhances antitumor effect based on passive tumor-targeting of liposomes. | 2011 Jul 1 |
4 |
| 34 |
21609741 | TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes. | 2011 Aug 25 |
7 |
| 35 |
21855130 | PEGylated TNF-related apoptosis-inducing ligand (TRAIL) for effective tumor combination therapy. | 2011 Nov |
1 |
| 36 |
20416058 | Doxorubicin and etoposide sensitize small cell lung carcinoma cells expressing caspase-8 to TRAIL. | 2010 Apr 23 |
3 |
| 37 |
20482316 | Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis. | 2010 Aug |
2 |
| 38 |
20659427 | Hypoxia inducing factor-1alpha regulates tumor necrosis factor-related apoptosis-inducing ligand sensitivity in tumor cells exposed to hypoxia. | 2010 Aug 27 |
1 |
| 39 |
20663232 | TRAIL sensitize MDR cells to MDR-related drugs by down-regulation of P-glycoprotein through inhibition of DNA-PKcs/Akt/GSK-3beta pathway and activation of caspases. | 2010 Jul 28 |
1 |
| 40 |
19625063 | Oxidative stress sensitizes bladder cancer cells to TRAIL mediated apoptosis by down-regulating anti-apoptotic proteins. | 2009 Sep |
1 |
| 41 |
19731037 | Conjugation of doxorubicin to cell penetrating peptides sensitizes human breast MDA-MB 231 cancer cells to endogenous TRAIL-induced apoptosis. | 2009 Nov |
6 |
| 42 |
19738990 | Synergistic antitumor effect of TRAIL and adriamycin on the human breast cancer cell line MCF-7. | 2009 Sep |
2 |
| 43 |
19843632 | Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells. | 2009 Nov |
1 |
| 44 |
20014456 | TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies. | 2009 Dec 21 |
1 |
| 45 |
18701496 | Sp1-mediated TRAIL induction in chemosensitization. | 2008 Aug 15 |
5 |
| 46 |
19106633 | TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death. | 2008 Dec |
2 |
| 47 |
17283156 | Evidence that tumor necrosis factor-related apoptosis-inducing ligand induction by 5-Aza-2'-deoxycytidine sensitizes human breast cancer cells to adriamycin. | 2007 Feb 1 |
4 |
| 48 |
17376311 | Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents. | 2007 Mar 5 |
2 |
| 49 |
17520194 | Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms. | 2007 Aug |
1 |
| 50 |
17649723 | [Study of molecular mechanism of doxorubicin enhancement of TRAIL, inducing apoptosis of myeloma cell line KM3]. | 2007 Jan |
6 |